Latest News

Infortrend High-Density 90-Bay Storage Helps Tackle Data Growth and Rack Constraints in Diverse Enterprise Deployments

TAIPEI, Dec. 3, 2025 /PRNewswire/ -- Infortrend Technology, Inc.  (TWSE: 2495), a leading provider of enterprise storage and AI solutions, today announced the growi...

2025-12-04 10:21 4438

Nona Biosciences Appoints Dr. Hongjiang Miao as Chief AI Officer to Advance A³ Strategy and AI-Driven Drug Discovery

CAMBRIDGE, Mass., Dec. 3, 2025 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea to IND), today announced the appointment of Dr.Hongjiang Miao as Chief AI Offic...

2025-12-04 10:01 2413

X-Design Takes #1 on Product Hunt with AI Agent That Democratizes Branding for Local Businesses

SYDNEY, Dec. 3, 2025 /PRNewswire/ -- X-Design , the AI branding platform built specifically for the brick-and-mortar economy, today announced it has achieved the #1 Product of the Day on Product Hunt. This milestone marks the launch of its newAI Agent

2025-12-04 10:00 2906

INCLUSION OF TINENGOTINIB TABLETS IN THE LIST OF PRODUCTS FOR PRIORITY REVIEW BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION

NANJING, China and GAITHERSBURG, Md., Dec. 3, 2025 /PRNewswire/ -- TransThera Sciences Nanjing, Inc. (the "TransThera") announced that Tinengotinib tablets have been included in the List of Products for Priority Review by the Center for Drug Evaluation ("CDE") of the National Medical Products Adm...

2025-12-04 09:57 1429

High Response in Bladder Cancer: Immvira Announced Its MVR-T3011 Latest Clinical Results in BCG-Unresponsive Bladder Cancer Patients at 2025 Annual Meeting of the Society of Urologic Oncology

SUZHOU, China, Dec. 3, 2025 /PRNewswire/ -- On December 3, 2025 (local time in Arizona, USA), ImmVira Group ("ImmVira" or the "Company") announced a poster presentation at the 26th Annual Meeting of the Society of Urologic Oncology (SUO 2025). The presentation featured the latest interim clinical...

2025-12-04 08:00 2229

POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results

GUANGZHOU, China, Dec. 3, 2025 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases inChina, today announced its unaudited financial results for the six months endedJune 30, 2025. Mr. Zhenyang Shi, Chairma...

2025-12-04 05:15 4768

Korea's Startups Poised for a Landmark Season as COMEUP 2025 and CES 2026 Draw Near

SEOUL, South Korea, Dec. 3, 2025 /PRNewswire/ -- Korea is preparing for a defining season in global innovation, asSeoul readies for COMEUP 2025—hosted by the Ministry of SMEs and Startups—and Korean entrepreneurs mark final preparations for their annual journey toLas Vegas for CES 2026. The two s...

2025-12-04 02:00 2604

ImpriMed to Present Ex Vivo Drug Sensitivity Data in Acute Myeloid Leukemia in Oral Presentation at American Society of Hematology Annual Meeting

Studies Demonstrate xCellSense® Platform's Ability to Predict Clinical Response and Enable Patient Stratification for Drug Development. PALO ALTO, Calif., Dec. 3, 2025 /PRNewswire/ -- ImpriMed

2025-12-04 01:00 1802

Filo Mail: The Quiet Revolution Transforming Email into a Proactive Assistant That Works for You

Built to Make Sure You Never Miss What Matters LOS ANGELES, Dec. 3, 2025 /PRNewswire/ -- Filo Mail is a radically reimagined Gmail client that transforms email from a cluttered archive into a focused command centre for meaningful action. Built with a single promise - to make sure you never miss ...

2025-12-04 00:00 2178

ONERugged 8-Inch Windows Rugged Tablet M82A Unveiled with a New Level of Power and Portability

SHENZHEN, China, Dec. 3, 2025 /PRNewswire/ -- ONERugged launched the smallest yet the strongest 8-inch Windows rugged tablet,M82A . Built for professionals who need performance on the move, the M82A combines compa...

2025-12-03 23:00 1982

TCab Tech E20 eVTOL Successfully Completes Transition Flight Tests

SHANGHAI, Dec. 3, 2025 /PRNewswire/ -- TCab Tech announced today that its full-scale E20 eVTOL demonstrator has successfully completed transition flight tests, marking a critical milestone in the program's development.

2025-12-03 22:35 1987

Infinix and Pininfarina Announce Strategic Design Partnership to Elevate the Future of Premium Smartphones

Collaboration Previews the Upcoming Infinix NOTE 60 Ultra designed by Pininfarina HONG KONG, Dec. 3, 2025 /PRNewswire/ -- Today, during the Business of Design Week 2025, Infinix announced a landmark strategic partnership with Pininfarina, the iconic Italian design house with a 95-year legacy of ...

2025-12-03 22:06 4298

Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results

BEIJING, Dec. 3, 2025 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial results for the three and nine months ended Se...

2025-12-03 18:04 3816

Westlake University Establishes Department of Astronomy

HANGZHOU, China, Dec. 1, 2025 /PRNewswire/ -- Westlake University held the founding ceremony for its Department of Astronomy at Yungu Campus onOct. 18, marking the establishment of the first astronomy department at a new type of research university inChina. Prof. Shude Mao, a renowned astrophysic...

2025-12-03 14:11 2111

What the Global South can learn from China's development

BEIJING, Dec. 2, 2025 /PRNewswire/ -- A news report by chinadiplomacy.org.cn on China's development experience for the Global South: The following is a transcript of a speech delivered by Koh King Kee, president of the Centre for New Inclusive Asia, aKuala Lumpur based independent think-tank, du...

2025-12-03 12:49 1698

The 110-Year Trans-Pacific Cultural Dialogue: Moutai's Dual Anniversary Brand Celebration Prepares for Grand Opening in the United States

SAN FRANCISCO, Dec. 2, 2025 /PRNewswire/ -- In commemoration of the 110th anniversary of Moutai's debut and award-winning at the Panama-Pacific International Exposition and the 10th anniversary of San Francisco Moutai Day, the Kweichow Moutai delegation led by Group Vice General ManagerZhang Guic...

2025-12-03 12:00 1695

Waterdrop Wins 2025 Global Best Case Brands Award, Empowering Inclusive Protection Through Technological Innovation

BEIJING, Dec. 2, 2025 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) was honored with the Global Best Case Brands Award at the 3rd International Conference on Management Change and Sustainable Development (MC&SD). Selected from more than 100 nominated companies, Waterdrop stood out for its significan...

2025-12-03 11:32 3663

X-Design Launched AI Agent: The Always-On Partner That Saves Small Business 70% of Branding time

SYDNEY, Dec. 2, 2025 /PRNewswire/ -- For small business owners, building a beautiful, consistent brand feels out of reach. Creating a logo in one app, designing a menu in another, and making social posts in a third often leads to scattered visuals tha...

2025-12-03 10:10 2675

DNAKE Donates Smart IP Intercom Systems to Habitat for Humanity Greater Los Angeles, Strengthening Home Security for Local Families

LOS ANGELES, Dec. 2, 2025 /PRNewswire/ -- DNAKE, a leading smart IP intercom manufacturer and home automation solutions provider, has donated a batch of Cloud-based IP Video Intercom Kits (IPK04), valued at more than$21,000, to Habitat for Humanity ofGreater Los Angeles (Habitat LA). The smart IP...

2025-12-03 09:00 2020

Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®

* FDA approval of OMLYCLO® (omalizumab-igec) 300 mg/2 mL solution in a single-dose prefilled syringe for subcutaneous injection expands dosing flexibility and supports tailored treatment for individual patients with certain allergic diseases * OMLYCLO® (omalizumab-igec) is the first and only ...

2025-12-03 08:43 4035